VPAG 2024: scheme documents and guidance
Publications covering the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG), a voluntary agreement between DHSC, NHS England and ABPI.
This collection brings together the following VPAG publications:
- summary of the heads of agreement: the terms of the agreement reached between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI) for a new voluntary scheme
- the full VPAG agreement
- the annual payment percentage, which sets out the payment due from members of VPAG
- decisions of the VPAG dispute resolution panel
There are separate collections on:
- VPAG operational review minutes (minutes of meetings held between the government, NHS England and ABPI about how VPAG is operating)
- VPAG quarterly net sales and payment information
Summary of the heads of agreement
Full VPAG agreement
Payment percentage for 2026
Previous payment percentages
Dispute resolution panel decisions
Updates to this page
-
Added 'The 2024 voluntary scheme for branded medicines pricing, access and growth: payment percentage for 2026'.
-
First published.